DF Clinical Symposium

A Practical Guide to Comorbidity Screening in Hidradenitis Suppurativa

Dr. Haley Naik presented information about practical comorbidity screening approaches for patients with hidradenitis suppurativa (HS). HS has been considered a rare disease, but more recent data show it is as common as other dermatologic conditions, including psoriatic arthritis and lichen…

Early Registration for the 2027 DF Clinical Symposium is Open

Early registration is now open for the Dermatology Foundation’s 24th annual Clinical Symposium, taking place January 27–30, 2027, at The Ritz-Carlton in Naples, Florida. Registration deadlines Early registration: September 16-October 31, 2026 Standard registration: November 1-December 15, 2026 Late registration: After December 16, 2026 Once you have registered, you will receive a confirmation email that includes a link and a code…

Making Progress in Hidradenitis Suppurativa Patient Care

Nearly three million Americans suffer from hidradenitis suppurativa (HS), an incredibly painful relapsing inflammatory skin disease characterized by debilitating boils and abscesses that can progress to dermal tunnels and scarring. “This is not a rare disease,” said Haley Naik, MD, MHSc, and professor in the Department of Dermatology, UCSF School of Medicine. “Yet, since its first report in the early 19th century, it has been under-recognized…

Dermatology Surgical Pearls

Dr. Marta Van Beek shared 4 surgical pearls for dermatologists. Pearl #1: Don’t underestimate the alar groove. When repairing a Mohs defect with a flap or graft, blunting of the alar groove can cause significant disfigurement externally and a “shelf” internally that disrupts air flow with inspiration…

Palliative Care in Dermatology

Dr. Marta Van Beek presented information about palliative care for dermatologists. Palliative care is designed to enhance patients’ and families’ quality of life (QOL) while negotiating serious illness. Dermatologists should know about palliative care because they may see certain patient…

Novel and Pipeline Therapies for Hidradenitis Suppurativa Management

Dr. Haley Naik presented information about new and emerging therapies for managing hidradenitis suppurativa (HS). The goal of HS management is to control inflammation and remove tissue that has been irreversibly damaged. First, Naik emphasized the importance of early intervention in halting…

Deepen Your Knowledge

Now in its 23rd year, this DF Clinical Symposium delivers high-impact, cutting-edge education across a wide range of dermatological topics. Thirteen expert speakers will present: Drs. Crystal Aguh, Jean Bolognia, Yvonne E. Chiu, Shawn Gaurav Kwatra, Haley Naik, Kishwer S. Nehal, Adam I. Rubin, Cory L. Simpson, Colleen K. Stockdale, Susan C. Taylor, Marta J….

Where Scientific Innovation, Discovery and Clinical Dermatology Converge

Michael Rosenblum, MD, PhD, was a 20-year-old undergraduate at the University of British Columbia when his mother became ill with breast cancer. At the time, physician-scientists were just beginning to explore how the immune system could be directed to target cancer cells. At the forefront was Dr. Steven Rosenberg, who had written a book that…

Skin Cancer Syndrome: Update on Gorlin Syndrome

Dr. Billingsley presented information about the etiology, diagnosis, and treatment of Gorlin syndrome. First, Dr. Billingsley discussed the etiology and epidemiology of Gorlin syndrome. Gorlin syndrome is a tumor predisposing disorder with systemic manifestations that affects approximately 11,000 people in the US. It is caused by a genetic mutation affecting the Sonic Hedgehog (SHH) signaling…

Scar Wars

Dr. Wysong presented information about scar assessment and treatment. First, Dr. Wysong discussed managing patient expectations for scar treatment. Scars are an outcome of the natural healing process when fibrous tissue replaces normal skin after skin injury. Patients should understand that their skin will never be exactly the same. Dr. Wysong makes sure to ask…